With shares of Amazon (NASDAQ:AMZN) trading around $274, is AMZN an OUTPERFORM, WAIT AND SEE or STAY AWAY? Let�� analyze the stock with the relevant sections of our CHEAT SHEET investing framework:
T = Trends for a Stock’s Movement
Amazon serves consumers through its retail websites and focus on selection, price, and convenience. The company also manufactures and sells Kindle devices. It offers programs that enable sellers to sell their products on its websites, their own branded websites, fulfill orders through them, and programs that allow authors, musicians, filmmakers, app developers, and others to publish and sell content. Online commerce has been on the rise because of the convenience, efficiency, and relatively low prices offered. Amazon is a leader in the Internet commerce space so look for them to continue to see rising profits, as consumers and companies opt for this method of shopping and selling over the standard method.
T = Technicals on the Stock Chart are Strong
Top 10 Trucking Companies For 2015: Albany International Corp (AIN)
Albany International Corp., incorporated in 1895, is an advanced textile and material processing company. The Company�� business is a producer of custom-designed fabrics and belts essential to paper and paperboard production. The consumable fabrics are used to manufacture all grades of paper from lightweight paper to heavyweight containerboard. The Company has five segments: Paper Machine Clothing segment (PMC), Engineered Composites (AEC), Albany Door Systems (ADS), Engineered Fabrics (EF) and PrimaLoft Products. Albany International supplies the worldwide pulp and paper industry, as well as other process industries, with technologically advanced structured materials and related services. The Company maintains manufacturing facilities in Brazil, Canada, China, France, Germany, the United Kingdom, Italy, Mexico, New Zealand, South Korea, Sweden, Turkey, and the United States. On January 11, 2012, the Company sold its assets in the Albany Door Systems (ADS) segment to ASSA ABLOY AB.
Paper Machine Clothing
During the year ended December 31, 2011, the Paper Machine Clothing (PMC) segment accounted for 81% of its total revenues. The Company designs, manufactures, and markets paper machine clothing for each section of the paper machine. PMC consists of permeable and non-permeable continuous belts of custom-designed and custom-manufactured engineered fabrics that are installed on paper machines and carry the paper stock through each stage of the paper production process. PMC products are consumable products of technologically design that utilize polymeric materials in a complex structure.
The Paper Machine Clothing segment�� products include forming, pressing, and dryer fabrics, and process belts. A forming fabric assists in sheet formation and conveys the very wet sheet (more than 75% water) through the forming section. Press fabrics are designed to carry the sheet through the press section, where water is pressed from the sheet as it passes through the press ni! p. In the dryer section, dryer fabrics manage air movement and hold the sheet against heated cylinders to enhance drying. Process belts are used in the press section to increase dryness and enhance sheet properties, as well as in other sections of the machine. The Company sells its PMC products directly to customer end-users, which are paper industry companies, some of which operate in multiple regions of the world. Its products, manufacturing processes, and distribution channels for PMC are substantially the same in each region of the world, in which the Company operates.
The Engineered Composites (AEC)
The Engineered Composites segment (AEC) provides custom-designed advanced composite structures based on technology to customers in the aerospace and defense industries. AEC�� is engaged in development program relates to the LEAP-X engine being developed by CFM International. Under this program, AEC is developing a family of composite parts, including fan blades, to be incorporated into the LEAP-X engine.
PrimaLoft Products segment
The PrimaLoft Products segment includes sale of insulation for outdoor clothing, gloves, footwear, sleeping bags, and home furnishings. This segment has sales operations in the United States, Europe, and Asia, through which it sells products produced by third parties. This segment also generates a portion of its income as royalties from the licensing of its intellectual property.
Engineered Fabrics segment
The Engineered Fabrics segment supplies consumable fabrics used to process paper pulp, as well as fabrics used in a range of industries other than papermaking. These other products include belts used to make non wovens, fiber cement building products, roofing shingles and corrugated sheets used in boxboard, as well as belts used in tannery and textile applications.
Advisors' Opinion:- [By Seth Jayson]
There's no foolproof way to know the future for Albany International (NYSE: AIN ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.
- [By Seth Jayson]
Albany International (NYSE: AIN ) reported earnings on May 1. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended March 31 (Q1), Albany International met expectations on revenues and missed estimates on earnings per share.
Top 10 Low Price Stocks To Buy Right Now: Reinsurance Group of America Inc (RGA)
Reinsurance Group of America, Incorporated (RGA) is an insurance holding company. RGA is engaged in the reinsurance of individual and group coverages for traditional life and health, longevity, disability income, annuity and critical illness products, and financial reinsurance. During the year ended December 31, 2011, approximately 65.8% of the Company�� net premiums were from its operations in North America, represented by its United States and Canada segments. Its subsidiaries include RGA Reinsurance Company (RGA Reinsurance), Reinsurance Company of Missouri, Incorporated (RCM), RGA Reinsurance Company (Barbados) Ltd. (RGA Barbados), RGA Americas Reinsurance Company, Ltd. (RGA Americas), RGA Atlantic Reinsurance Company, Ltd. (RGA Atlantic), RGA Life Reinsurance Company of Canada (RGA Canada), RGA Reinsurance Company of Australia, Limited (RGA Australia) and RGA International Reinsurance Company (RGA International). The Company has five geographic-based operational segments: United States, Canada, Europe & South Africa, Asia Pacific and Corporate and Other. On January 1, 2012, it dissolved its United Kingdom reinsurance subsidiary and transferred its business to RGA International, the Company�� Ireland-based subsidiary, to better manage capital resources.
As of December 31, 2011, the Company has operation in Australia, Barbados, Bermuda, People�� Republic of China, France, Germany, Hong Kong, India, Ireland, Italy, Japan, Mexico, the Netherlands, New Zealand, Poland, Singapore, South Africa, South Korea, Spain, Taiwan, the United Arab Emirates and the United Kingdom. The Company provides reinsurance products to the life insurance companies worldwide. The Company obtains its revenues through reinsurance agreements, which cover a portfolio of life and health insurance products, including term life, credit life, universal life, whole life, group life and health, joint and last survivor insurance, critical illness, disability income, as well as annuities and financial reinsurance.
!United States Operations
During 2011, the United States operations represented 54.4% of the Company�� net premiums. The United States operations market traditional life and health reinsurance, reinsurance of asset-intensive products, and financial reinsurance, primarily to the United States life insurance companies. The United States Traditional sub-segment provides life and health reinsurance to domestic clients for a range of products through yearly renewable term agreements, coinsurance, and modified coinsurance. Premiums vary for smokers and non-smokers, males and females, and may include a preferred underwriting class discount. Reinsurance premiums are paid in accordance with the treaty. Automatic reinsurance treaty provides that the ceding company will cede risks to a reinsurer on specified blocks of policies where the underlying policies meet the ceding company�� underwriting criteria. The United States facultative reinsurance operation involves the assessment of the risks inherent in multiple impairments, such as heart disease, high blood pressure, and diabetes; cases involving policy face amounts, and financial risk cases, which include cases involving policies disproportionately in relation to the financial characteristics of the proposed insured. During 2011, approximately 20.4% of the United States gross premiums were written on a facultative basis.
Canada Operations
During 2011, the Canada operations represented 11.4% of the Company�� net premiums. During 2011, approximately 85.2% of the recurring new business was written on an automatic basis. The Company operates in Canada through RGA Canada, a wholly owned subsidiary. RGA Canada is a life reinsurer in Canada, based on new individual life insurance production. It assists clients with capital management and mortality and morbidity risk management and is primarily engaged in traditional individual life reinsurance, as well as creditor, group life and health, critical illness, and longev! ity reins! urance. Creditor insurance covers the outstanding balance on personal, mortgage or commercial loans in the event of death, disability or critical illness and is shorter in duration than traditional life insurance. Clients include the life insurers in Canada.
Europe & South Africa Operations
During 2011, the Europe & South Africa operations represented 16.3% of the Company�� net premiums. This segment serves clients from subsidiaries, licensed branch offices and/or representative offices located in France, Germany, India, Ireland, Italy, Mexico, the Netherlands, Poland, South Africa, Spain, the United Arab Emirates and the United Kingdom. These offices operate primarily through the Company�� subsidiaries RGA International and RGA South Africa. The principal types of reinsurance for this segment include life and health products through yearly renewable term and coinsurance agreements, the reinsurance of critical illness coverage, which provides a benefit in the event of the diagnosis of a pre-defined critical illness and the reinsurance of longevity risk related to payout annuities. The reinsurance agreements of critical illness coverage may be either facultative or automatic agreements. Premiums earned from critical illness coverage represented 20.5% of the total net premiums for this segment during 2011. During 2011, the United Kingdom operations generated approximately 62.9% of the segment�� gross premiums.
Asia Pacific Operations
During 2011, the Asia Pacific operations represented 17.8% of the Company�� net premiums. The Company has a presence in the Asia Pacific region with licensed branch offices and/or representative offices in Hong Kong, Japan, South Korea, Taiwan, New Zealand, Labuan (Malaysia) and the People�� Republic of China. The principal types of reinsurance for this segment include life, critical illness, health, disability income, superannuation, and financial reinsurance. Superannuation is the Australian government mandated c! ompulsory! retirement savings program. Superannuation funds accumulate retirement funds for employees, and in addition, offer life and disability insurance coverage. Reinsurance agreements may be either facultative or automatic agreements covering primarily individual risks and, in some markets, group risks. During 2011, the Australian operations generated approximately 52.3% of the total gross premiums for the Asia Pacific operations. The Hong Kong, Labuan, Japan, Taiwan, China and South Korea offices provide full reinsurance services and are supported by the Company�� United States and International Division Sydney office.
Corporate and Other
Corporate and Other operations include investment income from invested assets not allocated to support segment operations and undeployed proceeds from the Company�� capital raising efforts, in addition to unallocated investment related gains or losses. Corporate expenses consist of the offset to capital charges allocated to the operating segments within the policy acquisition costs and other insurance expenses line item, unallocated overhead and executive costs, and interest expense related to debt. In additionally, Corporate and Other includes results from, among others, RGA Technology Partners, Inc. (RTP), a wholly owned subsidiary that develops and markets technology solutions for the insurance industry and the investment income and expense associated with the Company�� collateral finance facilities.
The Company competes with Munich Re, Swiss Re, Hannover Re, SCOR Global Re, Berkshire Hathaway and Generali.
Advisors' Opinion:- [By Selena Maranjian]
The biggest new holdings are Philip Morris International and Reinsurance Group of America (NYSE: RGA ) . Other new holdings of interest include Radian Group (NYSE: RDN ) . To say that mortgage insurer Radian had a good past year would be an understatement, as the stock more than tripled. That's partly due to expectations of a boom in business as the housing market picks up, with tighter lending rules probably leading to greater need for the coverage. The stock recently got an upgrade, with an analyst expecting a possibly bumpy 2013 because of a high level of delinquent loans, but much smoother sailing in following years.
- [By Brian Pacampara]
What: Shares of life and health reinsurer Reinsurance Group of America (NYSE: RGA ) sank 10% today after its quarterly results disappointed Wall Street.
- [By Brian Pacampara]
Based on the aggregated intelligence of 180,000-plus investors participating in Motley Fool CAPS, the Fool's free investing community, life and health reinsurer Reinsurance Group of America (NYSE: RGA ) has earned a coveted five-star ranking.
- [By David Sterman]
2. Reinsurance Group of America (NYSE: RGA) I've been singing the praises of insurance stocks throughout 2013, and though they have started to make solid upward moves, they are still quite undervalued. As long as their balance sheets are worth more than the public market value of their stocks, then you should pounce.This reinsurer (which insures the insurance companies against catastrophic payouts) is a perfect example. At the end of the second quarter, tangible book value stood at $82.97 a share. That's roughly 24% above the current stock price. And RGA is doing what any "below book" stock should do: buying back shares. The current buyback will be fueled by a $400 investment that should shrink shares outstanding by more than 5%.
Top 10 Low Price Stocks To Buy Right Now: Veolia Environnement(VE)
Veolia Environnement S.A., together with its subsidiaries, provides environmental management services to individuals, public authorities, and industrial and commercial services customers worldwide. It operates in four segments: Water, Environmental Services, Energy Services, and Transportation. The Water segment offers water and wastewater services, including the management and operation of large-scale and customized drinking water plants, wastewater decontamination and recycling plants, drinking water distribution networks, and wastewater collection networks; and provision of call centers and billing services. The Environmental Services segment provides waste management and logistical services, which include waste collection, waste processing, cleaning of public spaces, maintenance of production equipment, treatment of polluted soil, and management of waste discharge at industrial sites. The Energy Services segment offers a range of energy management services comprising o peration of heating and cooling networks, decentralized energy production, thermal and multi-technical services, industrial utilities, installation and maintenance of production equipment, integrated facilities management, and electrical services on public streets and roads; and provides heating systems maintenance services, plumbing and renewable energy services, and meter-reading services. The Transportation segment operates various bus networks, suburban trains, tramways, metros, and ferries, as well as offers customized transportation-on-demand services. This segment also provides intercity and regional passenger transportation, infrastructure management and airport services, and transportation management services. The company was formerly known as Vivendi Environnement and changed its name to Veolia Environnement S.A. in April 2003. Veolia Environnement S.A. was founded in 1853 and is headquartered in Paris, France.
Advisors' Opinion:- [By Benjamin Shepherd]
The first is to focus on infrastructure companies that lay the groundwork for easier water access, such as France-based Veolia Environment (NYSE: VE).
- [By Sean Williams]
Another factor that easily puts Waste Management on top in the waste-collection sector is its dividend yield of 3.4%. The only company with a higher yield is global waste solutions company Veolia Environnement (NYSE: VE ) , with a 6.2% yield. However, Veolia also boats a higher debt-to-equity ratio than Waste Management, has unwanted exposure to European markets, and has lower overall margins relative to Waste Management. By comparison, Republic Services, Progressive Waste, and Waste Connections pay out a yield of 2.7%, 2.4% and 1%, respectively. Even better, Waste Management's payout has grown by an average annualized rate of 7.7% since 2004.
Top 10 Low Price Stocks To Buy Right Now: Nuveen Credit Strategies Income Fund (JQC)
Nuveen Multi-Strategy Income & Growth Fund 2 (the Fund), formerly Nuveen Preferred and Convertible Income Fund 2, is a diversified, closed-end management investment company. The Fund intends to invest in a portfolio of preferred securities, securities and, to a lesser degree, high yield securities. The Fund may also invest in other debt instruments and common stocks acquired upon conversion of a convertible security.
On January 1, 2005, Nuveen Institutional Advisory Corp. (NIAC), the Funds' previous adviser, and its affiliate, Nuveen Advisory Corp. (NAC), were merged into Nuveen Asset Management (NAM), each wholly owned subsidiaries of Nuveen Investments, Inc. (Nuveen). As a result of the merger, NAM is the Adviser to all funds previously advised by either NIAC or NAC. The investment portfolio of the Fund includes JPMorgan Chase & Company, ING Group NV, Union Planters Corporation, HBSC Holdings Public Limited Company, Wachovia Corporation, Omnicare Capital Trust II, Hanover Compressor Capital Trust and CIT Group Incorporated.
Advisors' Opinion:- [By John Dowdee]
The following 10 funds satisfied all of these conditions:
BlackRock Float Rate Strategies (FRA). This CEF sells at a discount of 3%, which is low compared to an average premium of 2% over the past year. The distribution has been managed at 6.1% and a small amount (less than 10%) has been return of capital (ROC). However, this has not negatively affected net asset value (NAV) so has not been destructive. The fund holds 447 securities, with 90% in floating rate loans. FRA utilizes 27% leverage and has an expense ratio of 1.7%, including interest payments. Eaton Vance Floating Rate (EFR). This CEF sells at a 1% premium, which is low compared to an average premium of 5% over the past year. The distribution is 6.2%, none of which was ROC. The fund holds 800 securities, with 90% in floating rate loans. About 85% of the securities are from U.S. companies. EFR utilizes 35% leverage and has an expense ratio of 1.8% including interest payments. ING Prime Rate Trust (PPR). This CEF sells for a premium of 2%, which is below the average premium of 5%. It has a distribution of 6.8%, none of which was ROC. The fund has 350 holdings, virtually all in senior loans and from US companies. PPR utilizes 29% leverage and has a high expense ratio of 2.1%, including interest payments. Invesco VK Dynamic Credit Opportunities (VTA). This CEF sells for a discount of 5%, which is below the average discount of 1%. It has a distribution of 7.1%, none of which was ROC. The fund has 495 holdings, with 76% in floating rate loans. About 25% of the loans are from non-US companies. VTA utilizes a relatively low 20% leverage but still has a high expense ratio of 2.1%, including interest payments. Invesco VK Senior Income (VVR). This CEF sells for a discount of 1%, which is below the average premium of 3%. It has a distribution of 7.1%, none of which was ROC. The fund has over 500 holdings, with 89% in floating rate loans. Almost all (95%) securities are from US companies. VVR ut
Top 10 Low Price Stocks To Buy Right Now: Assurant Inc (AIZ)
Assurant, Inc. (Assurant) is a provider of specialized insurance products and related services in North America and select worldwide markets. The Company operates in four segments: Assurant Solutions, Assurant Specialty Property, Assurant Health, and Assurant Employee Benefits. The products offered by the segments include warranties and service contracts, pre-funded funeral insurance, lender-placed homeowners insurance, manufactured housing homeowners insurance, individual health and small employer group health insurance, group dental, disability, and life insurance and employee-funded voluntary benefits. On June 21, 2011, the Company acquired the SureDeposit business, the provider of security deposit alternatives to the multifamily housing industry. In October 2013, FirstService Corporation completed the sale of its Field Asset Services business to Assurant, Inc. In October 2013, Assurant Inc acquired Lifestyle Services Group Ltd.
Assurant Solutions
Assurant Solutions targets three product areas: domestic and international extended service contracts (ESC) and warranties, preneed life insurance, and international credit insurance. Through partnerships with retailers and original equipment manufacturers, the Company underwrites and provides administrative services for ESC and warranties. These contracts provide consumers with coverage on cellular phones, personal computers, consumer electronics, appliances, automobiles and recreational vehicles, protecting them from certain covered losses. It pays the cost of repairing or replacing customers��property in the event of mechanical breakdown, accidental damage, and casualty losses such as theft, fire, and water damage. The Company provides administration, claims handling and customer service. Preneed life insurance allows individuals to prepay for a funeral in a single payment or in multiple payments over a fixed number of years. The insurance policy proceeds are used to address funeral costs at death. These products are only so! ld in the United States and Canada and are generally structured as whole life insurance policies in the United States and annuity products in Canada.
The Company�� credit insurance products offer protection from life events and uncertainties that arise in purchasing and borrowing transactions. Credit insurance programs offer consumers the option to protect a credit card balance or installment loan in the event of death, involuntary unemployment or disability, and are generally available to all consumers without the underwriting restrictions that apply to term life insurance. In addition to the domestic market, the Company operates in Canada, the United Kingdom, Argentina, Brazil, Puerto Rico, Chile, Germany, Spain, Italy, Mexico and China. In these markets, it primarily sells ESC and credit insurance products through agreements with financial institutions, retailers and wireless service providers.
Assurant Specialty Property
The product line within Assurant Specialty Property is homeowners insurance, consisting principally of fire and dwelling hazard insurance offered through its lender-placed programs. The lender-placed program provides collateral protection to lenders, mortgage servicers and investors in mortgaged properties in the event that a homeowner does not maintain insurance on a mortgaged dwelling. Lender-placed insurance coverage is not limited to the outstanding loan balance; it provides structural coverage, similar to that of a standard homeowners policy. The policy is based on the replacement cost of the property and ensures that a home can be repaired or rebuilt completely in the event of damage. The Company also provides insurance to some of its clients on properties that have been foreclosed and are being managed by its clients. This type of insurance is called Real Estate Owned (REO) insurance. Lender-placed and voluntary manufactured housing insurance: Manufactured housing insurance is offered on a lender-placed and voluntary basis. Lender-plac! ed insura! nce is issued after an insurance tracking process similar to that described above. The tracking is performed by Assurant Specialty Property using an insurance tracking administration system, or by the lenders themselves.
The Company has developed products in adjacent and emerging markets, such as the lender-placed flood and mandatory insurance rental markets. It also acts as an administrator for the United States Government under the voluntary National Flood Insurance Program, for which it earns a fee for collecting premiums and processing claims. This business is 100% reinsured to the Federal Government. The Company offers its manufactured housing insurance programs primarily through manufactured housing lenders and retailers, along with independent specialty agents. The independent specialty agents distribute flood products and miscellaneous specialty property products. Multi-family housing products are distributed primarily through property management companies and affinity marketing partners. Its lender-placed homeowners insurance program and certain of its manufactured home products are not underwritten on an individual policy basis.
Assurant Health
Assurant Health offers medical insurance and short-term medical insurance to individuals and families in the medical insurance market. Its products are offered with different plan options. Assurant Health also offers medical insurance to small employer groups. The Company�� medical insurance products are sold to individuals, primarily between the ages of 18 and 64, and their families, who do not have employer-sponsored coverage. It offers a variety of benefit plans at different price points. The Company�� group medical insurance is primarily sold to small companies with 2 to 50 employees, although larger employer coverage is available. The Company�� health insurance products are principally marketed through a network of independent agents. It also markets through a variety of national account relationships ! and direc! t distribution channels. In addition, the Company markets its products through North Star Marketing, a wholly owned affiliate.
Assurant Employee Benefits
The Company offers group disability, dental, vision, life and supplemental worksite products, as well as individual dental products. The group products are offered with funding options ranging from fully employer-paid to fully employee-paid (voluntary). In addition, it reinsures disability and life products through its wholly owned subsidiary, Disability Reinsurance Management Services, Inc. (DRMS). Group disability insurance provides partial replacement of lost earnings for insured employees who become disabled, as defined by their plan provisions. The Company�� products include both short- and long-term disability coverage options. It also reinsures disability policies written by other carriers through its DRMS subsidiary.
Dental benefit plans provide funding for necessary or elective dental care. Customers may select a traditional indemnity arrangement, a preferred provider organization (PPO) arrangement, or a prepaid or managed care arrangement. Coverage is subject to deductibles, coinsurance and annual or lifetime maximums. In a prepaid plan, members must use participating dentists in order to receive benefits. Assurant Employee Benefits owns and operates Dental Health Alliance, L.L.C., a dental PPO network. The Company also has an agreement with Aetna that allows it to use Aetna�� Dental Access network. Fully insured vision coverage is offered through its agreement with Vision Service Plan, Inc., a supplier of vision insurance. The Company�� plans cover eye exams, glasses and contact lenses, and are sold in combination with one or more of its other products.
Group term life insurance provided through the workplace provides benefits in the event of death. The Company also provides accidental death and dismemberment (AD&D) insurance. Insurance consists primarily of renewable term life insu! rance wit! h the amount of coverage provided being either a flat amount, a multiple of the employee�� earnings, or a combination of the two. It also reinsures life policies written by other carriers through DRMS. In addition, the Company provides group critical illness, cancer, accident, and gap insurance. These products are paid for by the employee through payroll deduction, and the employee is enrolled in the coverage(s) at the worksite. Its products and services are distributed through a group sales force located in 34 offices near metropolitan areas.
Advisors' Opinion:- [By Rich Duprey]
Specialized insurance products provider�Assurant (NYSE: AIZ ) announced yesterday its third-quarter dividend of $0.25 per share, the same rate it paid last quarter after raising the payout 19%, from $0.21 per share.
Top 10 Low Price Stocks To Buy Right Now: Advanced Photonix Inc (API)
Advanced Photonix, Inc. (API), incorporated in June 22, 1988, is engaged in the development and manufacture of optoelectronic devices and value-added sub-systems and systems. The Company serves a variety of global original equipment manufacturers (OEMs) in a variety of industries. API supports its customers from the initial concept and design phase of the product, through testing to full-scale production. API has two manufacturing facilities located in Camarillo, California and Ann Arbor, Michigan. API is a supplier of optoelectronic semiconductors packaged into high-speed optical receivers, custom optoelectronic subsystems and Terahertz instrumentation, serving a variety of global OEM markets. API supports the customer from the initial concept and design of the semiconductor, hybridization of support electronics, packaging and signal conditioning or processing from prototype through full-scale production and validation testing. The target markets served by it are industrial sensing/NDT, military/aerospace, telecom, medical and homeland security. On March 1, 2013, it acquired certain assets of Silonex, Inc.
The Company�� high-speed optical receivers include avalanche photodiode (APD) technology and positive-intrinsic-negative (PIN) photodiode technology based upon III-V materials, including InP, InAlAs, and GaAs. Its optoelectronic subsystems are based on its silicon large area avalanche photodiode (LAAPD), PIN photodiode, FILTRODE detectors and light emitting diode (LED) assemblies. API�� Terahertz sensor product line is targeted at the industrial homeland security and military markets. Using its fiber coupled technology and high speed Terahertz generation and detection sensors, the Company is engaged in transferring Terahertz technology from the laboratory to the factory floor for use in non-destructive testing and real time quality control.
The Company competes with First Sensor, Illinois Tool Works, JDS Uniphase, Neophotonix, U2T and Nippon Electric.
Advisors' Opinion:- [By Bryan Murphy]
When most investors think of optical sensor makers, they tend to think of larger names like Honeywell International Inc.� (NYSE:HON) or Vishay Intertechnology (NYSE:VSH). And well they should. VSH is a $2 billion company, and HON is a $71.5 billion organization. The fact is, however, there are a few small cap stocks in the optical sensor space that are worth a look, and one of them is worth a very close look right now for a very clear reason... Advanced Photonix, Inc. (NYSEMKT:API).
- [By Monica Gerson]
Advanced Photonix (NYSE: API) is expected to post a Q4 loss at $0.01 per share on revenue of $7.04 million.
Sport Chalet (NASDAQ: SPCHB) is projected to post its quarterly earnings.
- [By Patricio Kehoe]
In 2010, the company acquired privately held Nimsoft, a provider of IT performance monitoring solutions for $350 million in cash. In Sep 2010, CA signed a definitive agreement to acquire Hyperformix Inc. Recently; it acquired Layer 7 Technologies, a leading provider of Application Programming Interface (API) security and management. Furthermore, the acquisition of Arcot Systems Inc., a privately held company that provides authentication and fraud prevention software, in a move to boost its security offerings. These acquisitions have helped the firm to strengthen its cloud computing infrastructure and would also help to generate better profitability from the existing technology assets.
Top 10 Low Price Stocks To Buy Right Now: Pharmacyclics Inc (PCYC)
Pharmacyclics, Inc., incorporated on April 19, 1991, is a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's clinical development and product candidates are small-molecule enzyme inhibitors designed to target biochemical pathways involved in human diseases. As of June 30, 2011, it had three drug candidates under clinical development and a number of preclinical lead molecules. This includes an inhibitor of Bruton�� tyrosine kinase (Btk) (PCI-32765) in Phase II studies in hematologic malignancies; a Btk inhibitor lead optimization program targeting autoimmune indications, an inhibitor of Factor VIIa (PCI-27483) in a Phase II clinical trial in pancreatic cancer, and a histone deacetylase (HDAC) inhibitor (PCI-24781) in Phase I and II clinical trials in solid tumors and hematological malignancies as of June 30, 2012.
As of June 30, 2012, the Company developed ibrutinib, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a variety of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin�� lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse B-cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its current or planned Phase Ib/II and Phase III development program. had development programs for B-cell malignancies and autoimmune diseases. For malignant indications it has developed PCI-32765, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a range of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin�� lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its Phase II development. It has developed an assay! to measure occupancy of Btk in PBMCs using a cell-permeable fluorescently-labeled derivative of PCI-32765.
Factor VII is an enzyme that becomes activated (FVIIa) by binding to the cell surface protein tissue factor (TF), a protein found in the body that helps to trigger the process of blood clotting in response to injury. TF is over expressed in many cancers including gastric, breast, colon, lung, prostate, ovarian and pancreatic cancers. In these tumors, the FVIIa/TF complex induces intracellular signaling pathways by activating protease activated receptor 2 (PAR-2), another cell-surface protein. This in turn increases the expression of interleukin-8 (IL-8), a protein produced by white blood cells and other immune cells in response to pathogenic stimulation, and vascular endothelial growth factor (VEGF), a signal protein produced by cells that stimulate the growth of blood vessels. Both proteins play an important role in tumor growth and metastases as well as angiogenesis (growth of new blood vessels). FVIIa/TF complex also initiates the coagulation (a process by which blood forms clots) processes implicated in the high incidence of thromboembolic (the process by which the blood clots within a blood vessel) complications seen in patients with TF-expressing cancers. Thromboembolic events are a cause of death in patients with cancer and anticoagulant treatment has been shown to improve survival in a variety of cancers (Klerk et al. JCO. 2005).
PCI-27483 Factor VIIa Inhibitor
The Company�� Factor VIIa inhibitor PCI-27483 is a first-in-human small molecule inhibitor that selectively targets FVIIa. As an inhibitor of FVIIa, PCI-27483 has two potential mechanisms of action: inhibition of intracellular signaling involved in tumor growth and metastases and inhibition of early coagulation processes associated with thromboembolism.
Factor VIIa PCI-27483 Clinical Development Update
A multicenter Phase I/II of PCI-27483 in patients with locally a! dvanced o! r metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). The objectives are to assess the safety of FVIIa Inhibitor PCI-27483 at pharmacologically active dose levels, to assess potential inhibition of tumor progression and to obtain initial information of the effects on the incidence of thromboembolic events. Due to a paradigm shift away from the use of gemcitabine alone for the treatment of pancreatic cancer, enrolling patients in this randomized study has been challenging. PCYC is evaluating other alternatives for development of this agent.
A multicenter Phase I/II of PCI-27483 in patients with locally advanced or metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). PCI-27483 is covered by United States patents and patent applications and counterpart patents and patent applications in fourteen ex-United States territories, including Europe, Canada, Mexico, Japan, China, India, South Korea, Australia and Brazil.
Advisors' Opinion:- [By Ben Levisohn]
Somaiya and team named Gilead and�Neurocrine Biosciences (NBIX) their top picks, hile putting Buy ratings on Celgene, Biogen Idec, Alexion (ALXN), Incyte (INCY), Pharmacyclics (PCYC) and Synageva (GEVA). BioMarin (BMRN), Infinity Pharmaceuticals (INFI) and Amgen (AMGN) earned Neutral ratings.
- [By Sean Williams]
The other factor that makes J&J a company I wouldn't dare bet against is its top-notch pharmaceutical program. J&J has delivered incredible wins over the past couple of quarters including the approval of Invokana, the first SGLT-2 inhibitor approved in the U.S. to treat Type 2 diabetes, as well as its December 2011 licensing partnership with Pharmacyclics (NASDAQ: PCYC ) over experimental drug, ibrutinib, which has been designated as a breakthrough therapy by the Food and Drug Administration for the treatment of two rare blood cancers and could generate up to $5 billion in peak sales if approved (it's currently under review by the FDA).
- [By Sean Williams]
Biotechnology juggernaut Pharmacyclics (NASDAQ: PCYC ) -- a company that has returned close to 19,000% since its recession lows -- ignited investor optimism when it and licensing partner Johnson & Johnson (NYSE: JNJ ) filed a new drug application for ibrutinib. This is truly exciting news, because it marks the first breakthrough therapy drug that's filed for an NDA, and will act the test subject to the rest of the breakthrough therapy designated drugs. Ibrutinib delivered exceptional results in chronic lymphocytic leukemia and mantle cell lymphoma in terms of overall response rate, which should probably net it an approval from the Food and Drug Administration.
No comments:
Post a Comment